The Agency for Healthcare Research & Quality releases a series of Statistical Briefs based on the Medical Expenditure Panel Survey. The latest one describes physician visits in 2016. (AHRQ Statistical Brief) About 35% of all visits were to primary care physicians, with another 9% to pediatricians, 6% to ob/gyn, 7.4% to eye doctors, 5.5% to orthopedists and 4.6% to psychiatrists. The average expense for a physician visit was $265 across all specialties, but the median expense was only $116; which reflects a lower average visit cost for the most common specialties. Average cost for a primary care visit was $186, and it was $169 for a pediatrician and $159 for a psychiatrist. On the other end, an average bill for a trip to the orthopedist was $419 and to a cardiologist $335. 55% of all physician visits had no copayment. This also varied across specialties, with 66% of pediatrician visits not having cost-sharing and 63% of ob/gyn appointments. But only 44% of opthalmologist and 41% of dermatologist visits had no cost-sharing. Median out-of-pocket payment for those visits with some cost-sharing was $30, with a range of $25 for pediatrician and primary care doctors to $40 for orthopedists, dermatologists and eye doctors. Mean or average out-of-pocket payments were higher than median ones. For example the average cost-sharing on a pediatric visit was $40 and for ophthalmologists it was $125. Across payer types, as you might expect, Medicaid enrollees paid the least out-of-pocket, followed by Medicare beneficiaries, with commercial insureds having the greatest cost-sharing, and total expense for a visit followed a similar pattern. There was some variation among specialties depending on payer type as well. One take-away would be that there is less cost-sharing for doctor visits than one might expect, but this is probably overly influenced by the high number of people on Medicaid who have no cost-sharing in most cases.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
Commentary
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
Commentary
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…